Persistent NKH with transient or absent symptoms and a homozygous GLDC mutation.
Korman SH, Boneh A, Ichinohe A, Kojima K, Sato K, Ergaz Z, Gomori JM, Gutman A, Kure S.
Korman SH, et al.
Ann Neurol. 2004 Jul;56(1):139-43. doi: 10.1002/ana.20159.
Ann Neurol. 2004.
PMID: 15236413
Three of four nonketotic hyperglycinemia patients homozygous for a novel GLDC mutation (A802V) were treated by assisted respiration and/or sodium benzoate with or without ketamine and had transient neonatal or absent symptoms and normal developmental outcome, …
Three of four nonketotic hyperglycinemia patients homozygous for a novel GLDC mutation (A802V) were treated by assisted respiration a …